Advertisement
Advertisement

ONVO

ONVO logo

Organovo Holdings Inc

0.3624
USD
-0.0066
-1.79%
Dec 18, 14:01 UTC -5
Closed
...

Organovo Holdings Inc Profile

About

Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings, Inc. is based in San Diego, California.

Info & Links

CEO

Keith Murphy

Headquarters

11555 SORRENTO VALLEY ROAD, SUITE 100
SAN DIEGO, CA 92121, UNITED STATES

Auditor

Rosenberg Rich Baker Berman P.A.

Share holders

82

Employees

20

Organovo Holdings Inc Statistics

Valuation Measures

Market Capitalization2

5.57M

Enterprise Value

2.40M

Enterprise Value/EBITDA(ttm)

-0.19

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

60.36

Price to Book(mrq)

1.69

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

97.88%

Operating Margin(ttm)

-12176.70%

Profit Margin(ttm)

-24912.76%

Return on Equity(ttm)

-249.28%

Return on Invested Capital(ttm)

-262.32%

Return on Assets(ttm)

-159.50%

Income Statement

Revenue(ttm)

103.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

100.00K

EBITDA(ttm)3

-12.49M

Net Income Available to Common(ttm)

-12.54M

Diluted EPS(ttm)

-1.06

Share Statistics

Beta (5Y Monthly)

0.53

52-Week Change

-69.80%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

15.37M

Dividend Yield

0.00%

Float4

14.79M

% Held by Insiders

3.72%

% Held by Institutions

8.23%

Balance Sheet

Total Cash(mrq)

3.17M

Total Cash Per Share(mrq)

0.21

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.98%

Quick Ratio(mrq)

1.72%

Book Value Per Share(mrq)

0.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.31

Free Cash Flow(ytd)

-5.64M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement